Weight-adjusted waist index · stroke risk

Weight-Adjusted Waist Index: Stroke Risk Screening in Hypertension

In hypertensive adults aged 60 and older, a higher weight-adjusted waist index predicted new stroke after body mass index and waist circumference were already accounted for; the top quartile, an index of 10.80 or above, carried 1.87 times the stroke hazard of the bottom quartile.

Blood pressure visits record a cuff reading and a weight. The measurement that separates older hypertensive patients by stroke risk needs one more number, taken with a tape.

The weight-adjusted waist index is waist circumference in centimeters divided by the square root of body weight in kilograms, and in older adults with hypertension it predicts incident stroke after body mass index and waist circumference are already in the model. The hypertension visit records a cuff reading and a weight; the measurement that separates these patients by stroke risk needs a tape, and confirming what it means takes body composition analysis.

What the Xinjiang hypertension cohort found

The index was proposed in a Korean nationwide cohort of 465,629 subjects, where it showed the best predictive performance for cardiovascular mortality among the anthropometric measures tested. Its stroke signal in hypertension comes from a hospital-based cohort at the People’s Hospital of Xinjiang Uygur Autonomous Region in China: 4,962 hypertensive individuals aged 60 years or older with no prior stroke. Over a median follow-up of 3.2 years there were 547 new-onset strokes.

Per standard deviation of the index, the adjusted hazard ratio for stroke was 1.30 (95% CI 1.18 to 1.42).
The top quartile, an index of 10.80 or above, carried a hazard ratio of 1.87 against the bottom quartile.
The model adjusted for body mass index, waist circumference, systolic and diastolic pressure, hypertension duration, diabetes, lipids, homocysteine, renal function, high-sensitivity C-reactive protein and antihypertensive, antidiabetic and lipid-lowering drugs.
Adding the index to established risk factors moved the C-statistic from 0.534 to 0.575, and its area under the curve for stroke, 0.632, exceeded that of body mass index and waist circumference.

Mean body mass index was 22.37 in the lowest quartile and 25.93 in the highest. The patients carrying nearly double the stroke hazard were, by the scale, what most charts call mildly overweight at worst. This is a Chinese cohort, and the practice position is settled: a normal-BMI East Asian population is thin outside and fat inside, metabolically inflamed and insulin resistant. The bottom quartile is a reference group, not a healthy one, and the misclassified normal-weight patient is the subject of screening for the risk that BMI misclassifies.

Why a waist index sees what body mass index misses

Body mass index cannot tell muscle from fat, and waist circumference alone rises with overall size. Dividing waist by the square root of weight standardizes central adiposity for body size. The Xinjiang authors note the index is associated with a higher probability of having both high fat mass and low muscle mass, which is precisely the property that matters in geriatrics.

The non-obvious consequence is arithmetic. Weight sits in the denominator. An older patient who loses muscle loses weight, body mass index improves, the belt size barely moves, and the index climbs. The chart records success while the index records sarcopenic wasting under an unchanged abdominal depot. For years the reflex in most clinics, mine included, was to praise that weight loss in an older hypertensive patient. In a patient over 60, weight falling with a stable waist is a reason to measure composition, not to congratulate.

Two biological drivers carry the depot to the cerebral circulation. Visceral fat is an inflammatory organ: it sustains metaflammation, drives endothelial dysfunction and holds the patient in an insulin-resistant, proatherogenic state. Central adiposity also stokes sympathetic outflow and the renin-angiotensin system, which stiffens arteries, the change arterial stiffness testing quantifies, and makes pressure harder to control with every added drug. The third driver is structural. The hypertension visit is built around a cuff and a scale, waist circumference has no routine field in most workflows, and a food supply saturated with acellular carbohydrate and industrial seed oil builds the depot for years before weight crosses anyone’s threshold. In people rather than cohorts, the same depot shows up as aching in several places at once, covered in whether belly fat can cause chronic pain.

How the signal holds up in newer cohorts

Evidence from 2025 and 2026 carries the finding well beyond one Chinese hospital:

UK Biobank, 2026. In 398,270 participants without prior stroke, the index had the strongest associations among the obesity measures compared. The top quartile carried hazard ratios for ischemic stroke of 1.25 in men and 1.36 in women, and the index beat body mass index for ischemic stroke discrimination in both sexes (men, C-statistic 0.712 versus 0.688; women, 0.748 versus 0.726).
China Health and Retirement Longitudinal Study, 2025. Among 12,580 adults aged 45 and above, 727 had a stroke. The index predicted stroke in participants with hypertension (hazard ratio 1.13), and hypertension accounted for 12% of its total effect. Blood pressure control alone does not neutralize the depot.
ACCORD, 2025. In type 2 diabetes the index predicted congestive heart failure with a hazard ratio of 1.20 per standard deviation, beyond stroke alone.

One disagreement belongs in the interpretation. The Xinjiang cohort reported an association with hemorrhagic stroke as well as ischemic stroke; in UK Biobank no significant association was observed for hemorrhagic stroke. The reproducible signal is ischemic. The Xinjiang data are single-region, rest on one baseline measurement and carry no physical activity or dietary data, which the authors state plainly. None of that weakens the case for measuring a waist. It limits how literally any one cut-off should be imported into a St. Louis panel. The same body composition lens has been turned on the brain, set out in how fat and muscle patterns relate to later dementia.

Who to screen and what a high index changes

Adults aged 60 and older with hypertension, at every blood pressure visit, with waist measured by a consistent protocol.
Hypertensive patients with a normal or modestly elevated body mass index, particularly East Asian and South Asian patients.
Older patients whose weight is falling without a matching fall in waist circumference.
Patients with diabetes, dyslipidemia or fatty liver whose blood pressure is controlled but whose global risk has not been reassessed.

Written selection criteria keep the list reproducible across clinicians.

A high index should not, on its own, push antihypertensive intensification in a frail patient. It relocates the patient into active vascular prevention and aims treatment at the depot and at muscle: food composition, resistance and walking programs, sleep and alcohol, each prescribed with its physiological rationale, with the index and body composition repeated to show whether the waist moved relative to weight. Where pressure control is being tightened in an older patient, the standing reading matters as much as the seated one, as set out in what a seated blood pressure reading misses.

What the measurements add

Measura [Cardiometabolic and Autonomic Health Analysis] is a testing service; it measures and reports to the ordering physician and does not treat. Waist and weight belong in every visit. What Measura adds is the physiology behind the index:

Bioimpedance body composition separates fat mass from muscle mass, confirming whether a high index reflects abdominal fat, lost muscle or both.
Arterial stiffness and endothelial function, the vascular consequence of the inflammatory depot and the substrate of ischemic stroke.
Ankle-brachial index with toe-brachial measurement, for the systemic atherosclerosis that travels with cerebrovascular disease.
Cardiac autonomic reflex tests, for the pressure and heart rate responses to standing and breathing that decide how safely a regimen can be tightened.

Standing orders and the wellness visit

A waist circumference is worthless unless it is taken the same way every time, so it belongs in standing orders rather than in the memory of whoever rooms the patient. The annual wellness visit already structures risk review, cognition and falls; recording the index there, beside composition and vascular findings, turns a single anthropometric number into a trajectory (see annual wellness visit integration). The documented measures this testing supports are covered in quality measures that cardiometabolic testing supports. Unmeasured is unmanaged, and a stroke risk hiding behind a normal body mass index is the most unmanaged risk in the room.

Frequently asked questions

How is the weight-adjusted waist index calculated and interpreted?

Divide waist circumference in centimeters by the square root of weight in kilograms. In the Xinjiang cohort the mean was 9.99 and the highest-risk quartile began at 10.80; a Chinese longitudinal cohort of 13,046 adults found cardiovascular risk rising above an inflection near 10. Treat these as cohort-specific reference points rather than universal thresholds, and track change within the patient. The same depot logic underlies metaflammation screening in primary care.

Does the index replace body mass index in cardiovascular risk assessment?

It works best alongside it. The derivation study found the index combined with body mass index was the strongest pairing in both diagnostic and prognostic models, and the stroke cohorts adjusted for body mass index and still found an independent signal. Body mass index describes size; the index describes central fat relative to size. Other overlooked cardiovascular signals in primary care are reviewed in erectile dysfunction as a cardiovascular risk marker.

Should a high index change blood pressure targets in an older patient?

The index predicts stroke; it does not set a pressure target, and the Xinjiang association held after adjustment for pressure and medication. In older adults the sound sequence is to document orthostatic responses and autonomic function before intensifying, then treat the depot and muscle directly. Medication decisions remain with the treating physician. Baseline measurement before any regimen change is argued in deprescribing starts with a baseline, not a drug list.

Why pair the index with fall and bone assessment in geriatrics?

A rising index can mean muscle is disappearing beneath a stable waist, and lost muscle is a fall risk in its own right. The same hypertensive patient is often on several pressure-lowering drugs and low in vitamin D. Composition, balance and vitamin D status belong in the same encounter as the tape measure, as discussed in vitamin D screening and what falls risk adds.

Does a normal ankle-brachial index rule out vascular disease in these patients?

A normal resting value does not exclude disease, particularly in older patients with diabetes or kidney disease, where calcified, incompressible arteries falsely raise the reading. That is why toe-brachial measurement and arterial stiffness sit alongside it in a patient with a high waist index. The mechanism and the patterns to watch for are explained in why a normal ankle-brachial index can be misleading.

Bring body composition into hypertension care

See how the Measura protocol adds composition, vascular and autonomic measurements to the blood pressure visit, and how findings return to your chart.

Send a message

4477 Woodson Rd, Suite 201, St. Louis, MO 63134. Monday to Friday, 9:00 a.m. to 5:00 p.m. Please do not send symptoms, diagnoses or images through a web form — a website form is not a secure medical channel. Send your name and number and we will call you back.

References

Hu, J., Cai, X., Song, S., Zhu, Q., Shen, D., Yang, W., Hong, J., Luo, Q., et al. (2024). Association between weight-adjusted waist index with incident stroke in the elderly with hypertension: a cohort study. Scientific Reports, 14(1), 25614. https://doi.org/10.1038/s41598-024-76709-y
Park, Y., Kim, N. H., Kwon, T. Y., & Kim, S. G. (2018). A novel adiposity index as an integrated predictor of cardiometabolic disease morbidity and mortality. Scientific Reports, 8(1), 16753. https://doi.org/10.1038/s41598-018-35073-4
Li, F., Wang, Z. Y., Qi, S. S., Xu, Y. M., & Shi, C. H. (2026). Predictive value of traditional and novel obesity indices for stroke and its subtypes across sexes and glucose status: toward precision prevention strategies. Journal of the American Heart Association, 15(6), e043083. https://doi.org/10.1161/JAHA.125.043083
Xu, F., Liu, H., Li, M., Zhang, M., Chen, X., & Hou, M. (2025). Hypertension mediates the association between weight-adjusted waist index and new onset stroke risk in middle-aged and older Chinese adults: evidence from the CHARLS study. Frontiers in Neurology, 16, 1587176. https://doi.org/10.3389/fneur.2025.1587176
Liu, M., Pei, J., Zeng, C., Xin, Y., Tang, P., & Hu, X. (2025). Associations and predictive value of weight-adjusted waist index for cardiovascular outcomes in type 2 diabetes: evidence from the ACCORD study. Nutrition Journal, 24(1), 184. https://doi.org/10.1186/s12937-025-01251-0
Wang, J., Zhu, A., Zeng, R., Chen, L., Xie, F., Zhu, K., Fan, T., Ye, D., et al. (2025). A J-shaped association between weight-adjusted waist index and cardiovascular disease: a longitudinal study from the CHARLS database. BMC Public Health, 25(1), 4041. https://doi.org/10.1186/s12889-025-25127-4